| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -3,799,240 | -4,674,901 | ||
| Deemed dividend related to warrant modification | 0 | 0 | ||
| Net loss attributable to common stockholders | -3,799,240 | -4,674,901 | ||
| Net loss per share applicable to common stockholders basic and diluted (in dollars per share) | -5 | -0.17 | ||
| Weighted average number of common shares basic and diluted (in shares) | 760,502 | 27,593,952 | ||
Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)